Staff

Oxford Nanopore Announces That It Has Entered Into a Non-exclusive Agreement With Caribou Biosciences for CRISPR-Cas9 Enrichment for Nanopore Sequencing

OXFORD, England, Sept. 19, 2019 /PRNewswire/ -- Oxford Nanopore and Caribou Biosciences, Inc. have entered into a non-exclusive license agreement...

AIM ImmunoTech Inc. Announces the U.S. Department of Defense’s Award of $6.42M to Roswell Park Comprehensive Cancer Center to Study Ampligen as Part of a New Treatment of Brain-Metastatic Breast Cancer

error: Content is protected !!